Cargando…

What should be the best dialysis catheter lock in critically ill patients?

Detalles Bibliográficos
Autores principales:	Honore, Patrick M., Gutierrez, Leonel Barreto, Redant, Sebastien, Kaefer, Keitiane, Gallerani, Andrea, De Bels, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822461/ https://www.ncbi.nlm.nih.gov/pubmed/31666110 http://dx.doi.org/10.1186/s13054-019-2640-1

Ejemplares similares

Obesity inducing acute respiratory distress syndrome: we should choose the right population!
por: Honore, Patrick M., et al.
Publicado: (2019)

Dysbiosis of the microbiota in neurocritically ill patients associated with coma and death: ammonia as a potential missing link
por: Honore, Patrick M., et al.
Publicado: (2019)

How levosimendan can improve renal function?
por: Honore, Patrick M., et al.
Publicado: (2019)

MR-proADM has a good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: Beware of some potential confounders!
por: Honore, Patrick M., et al.
Publicado: (2022)

Interleukin-26 is a promising biomarker of sepsis but is it always reliable?
por: Honore, Patrick M., et al.
Publicado: (2019)

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
por: Honore, Patrick M., et al.
Publicado: (2019)

Biomarker suPAR seems a good prognostic factor for community-acquired pneumonia but less prominent for septic shock
por: Honore, Patrick M., et al.
Publicado: (2019)

High levels of plasma biomarkers at 24 h were found to be strong predictors of 90-day mortality: beware of some potential confounders!
por: Honore, Patrick M., et al.
Publicado: (2021)

A Study Revealed That a High Percentage of Patients With Severe COVID-19 With Viral RNAaemia Had Significantly Worse Outcomes, and This Is the First Report About the Risk Factors of Viral RNAaemia in Patients With COVID-19: We Are Not Sure!
por: Honore, Patrick M., et al.
Publicado: (2021)

Spontaneous Pneumothorax (SP) in COVID-19 Is Associated With Worse Outcomes Than SP in Non-COVID-19 Patients, Which Suggests That SP in COVID-19 is a Sign of Disease Severity: Is This Finding a Pure Association or Is There Really a Strong Relationship Between the Two?
por: Honore, Patrick M., et al.
Publicado: (2021)

Are SOFA score, PaO(2)/FiO(2) ratio, lymphocytes levels, total bilirubin, lactate dehydrogenase, ferritin, C-reactive protein and interleukin-6 significantly normalized following TPE completion: Is this fact or fiction?
por: Honore, Patrick M., et al.
Publicado: (2021)

Study conclude that routinely monitoring of sputum viral load in severe COVID-19 patients may be beneficial for development of infection control guidelines and prediction of prognosis: We are not sure!
por: Honore, Patrick M., et al.
Publicado: (2022)

Indirect calorimetry is the gold standard to assess REE in ICU patients: some limitations to consider
por: Honore, Patrick M., et al.
Publicado: (2021)

Study find that COVID ARDS was associated with a low risk for possible or proven PCP: still true after dexamethasone use
por: Honore, Patrick M., et al.
Publicado: (2022)

Success rate of naso-jejunal tube placement influenced by CRRT: possible removal of metoclopramide
por: Honore, Patrick M., et al.
Publicado: (2021)

Higher incidence of arrhythmia in COVID-19 than in other community-acquired pneumonia: possible role of concurrent therapies
por: Honore, Patrick M., et al.
Publicado: (2021)

Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
por: Honore, Patrick M., et al.
Publicado: (2018)

Study conclude that TXA in severely injured was associated with lower mortality: beware of potential confounders
por: Honore, Patrick M., et al.
Publicado: (2021)

Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
por: Honore, Patrick M., et al.
Publicado: (2022)

Anisodamine microcirulatory effects in septic shock: be aware of cardiac side effects
por: Honore, Patrick M., et al.
Publicado: (2021)

Is endocan correlated to ARDS severity or an epiphenomenon of thrombo-embolic disease in COVID
por: Honore, Patrick M., et al.
Publicado: (2021)

Membrane adsorption in vancomycin treatment is membrane type dependent in CVVHDF: dose correction is crucial
por: Honore, Patrick M., et al.
Publicado: (2022)

Hepcidin is described as the master regulator of iron: could its removal by CRRT lead to iron dysmetabolism in the critically ill?
por: Honore, Patrick M., et al.
Publicado: (2020)

Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider
por: Honore, Patrick M., et al.
Publicado: (2020)

Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction?
por: Honore, Patrick M., et al.
Publicado: (2020)

Risk of harlequin syndrome during bi-femoral peripheral VA-ECMO: should we pay more attention to the watershed or try to change the venous cannulation site?
por: Honore, Patrick M., et al.
Publicado: (2020)

Detecting influenza-associated pulmonary aspergillosis by determination of galactomannan in broncho-alveolar lavage fluid and in serum: should we add (1,3)-beta-D-glucan to improve efficacy
por: Honore, Patrick M., et al.
Publicado: (2020)

Patients with emm1/T1 serotype invasive group A streptococci infections demonstrated more renal failure than patients with other serotypes: perhaps we should consider some confounders
por: Honore, Patrick M., et al.
Publicado: (2020)

Difference of 11 years between two periods of VV-ECMO does not impact mortality in large centres: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2022)

Clostridioides difficile infection in the critically ill: what kind of therapy for refractory cases
por: Honore, Patrick M., et al.
Publicado: (2020)

Icatibant, another piece of the therapeutic puzzle regarding hemodynamic side effects of angiotensin-converting enzyme inhibitors
por: Honore, Patrick M., et al.
Publicado: (2019)

Endotoxin removal by polymyxin B: is it a question of dose or duration or both?
por: Honore, Patrick M., et al.
Publicado: (2019)

Sevoflurane and nephrogenic diabetes insipidus on the rise: copeptin to the rescue?
por: Honore, Patrick M., et al.
Publicado: (2019)

Endarterectomy treatment for patients suffering from a new episode of pulmonary embolism, after screening for chronic thromboembolic pulmonary hypertension
por: Honore, Patrick M., et al.
Publicado: (2022)

Is cortical perfusion a reliable marker for predicting septic acute kidney injury?
por: Honore, Patrick M., et al.
Publicado: (2019)

TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status: fact or fiction?
por: Honore, Patrick M., et al.
Publicado: (2020)

High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?
por: Honore, Patrick M., et al.
Publicado: (2020)

Mortality in non-elderly septic patients was increased with hypothermia and decreased with fever while mortality in elderly patients was not associated with body temperature: beware of some confounders!
por: Honore, Patrick M., et al.
Publicado: (2020)

A retrospective study in adult patients with septic shock and multiple organ failure demonstrated improved 28-day survival with adjunct TPE compared to standard care alone: true effect or mediated by a negative fluid balance achieved by RRT?
por: Honore, Patrick M., et al.
Publicado: (2020)

Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO
por: Honore, Patrick M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a1b7soot7mfb7mfqk4ir6iabg2